Clik here to view.
The SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready Launches at...
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, launches the next generation of its flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System...
View ArticleClik here to view.
武田薬品とニューヨーク科学アカデミーが2020年Innovators in Science Awardの受賞者を発表
ニューヨーク & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（以下、「武田薬品」）（TSE:4502/NYSE:TAK）とニューヨーク科学アカデミーは本日、今年で第3回年次Innovators in Science...
View ArticleClik here to view.
RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical Trial...
TOKYO RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (TOKYO:4591), today announced that the...
View ArticleClik here to view.
BostonGene and NEC Collaborate to Analyze Cancer Patients in Clinical Trials
WALTHAM, Mass. & TOKYO BostonGene Corporation (BostonGene), a biomedical software company focused on defining optimal precision medicine-based therapies for cancer patients, and NEC Corporation...
View ArticleClik here to view.
Promega Surpasses Environmental Improvement Goals and Achieves Absolute...
MADISON, Wis. Promega Corporation has surpassed all its environmental improvement goals set for the end of 2020, and achieved absolute reductions in key sustainability metrics, according to the...
View ArticleClik here to view.
Largest Global Forensic DNA Meeting, International Symposium on Human...
MADISON, Wisc. Forensic DNA experts from around the world will gather virtually in 2020 for the 31st International Symposium on Human Identification (ISHI). The largest annual meeting focusing...
View ArticleClik here to view.
National Hemophilia Foundation and Takeda Partner with Alex Borstein to Raise...
LEXINGTON, Mass. & OSAKA, Japan Up to one in every 100 Americans is affected by von Willebrand disease1 (VWD) – but how many have heard of this condition? A new series of public service...
View ArticleClik here to view.
Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His...
TOKYO The Edogawa NICHE Prize for the year 2020 has been awarded to Dr. John Craig Venter for his contribution to research and development pertaining to the Human genome. This honor reflects Dr....
View ArticleClik here to view.
John Craig Venter研究员因在人类基因组研究领域的成就而荣获2020年江户川-NICHE奖
东京 (美国商业资讯)–2020年江户川NICHE奖授予John Craig Venter博士，以表彰其对人类基因组相关研究和进展的贡献。江户川NICHE评奖委员会主席Gary Levy教授表示，该荣誉反映了Venter博士在基因组学领域的终身成就，特别是人类基因组鉴定，后者已从根本上改变了医疗保健领域(www.edogawanicheprize.org)。...
View ArticleClik here to view.
ジョン・クレイグ・ベンター博士が2020年江戸川ニッシュ賞を受賞 ― ヒトゲノム研究での功績により
東京 （ビジネスワイヤ） — 2020年江戸川ニッシュ賞は、ヒトゲノムに関する研究が評価され、ジョン・クレイグ・ベンター博士に授与されることが発表されました。江戸川ニッシュ賞委員会（www.edogawanicheprize.org）委員長のギャリ・レビ教授は、「今回の授賞は、医療を根本的に改革したヒトゲノムの同定における博士の功績を称えるものである」と話しました。...
View ArticleClik here to view.
Aroa Biosurgery’s Endoform® Platform Shown to Attract Stem Cells
AUCKLAND, New Zealand Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘Aroa’ or the ‘Company’) has gained further validation for Endoform®, its flagship extracellular matrix...
View ArticleClik here to view.
Modalis Therapeutics Reports Second Quarter 2020 Financial Results and...
TOKYO & CAMBRIDGE, Mass. Modalis Therapeutics Corporation (Modalis) (TOKYO: 4883), a leading company developing innovative products for the treatment of rare genetic diseases utilizing its...
View ArticleClik here to view.
MEDIROM Announces Discovery of Disease Factors via Lifestyle DataBase x AI...
TOKYO Revorf Co., Ltd. and MEDIROM Healthcare Technologies Inc. are pleased to announce that they have entered into a business collaboration agreement as of September 1st, 2020. This press release...
View ArticleClik here to view.
Promega Launches Spectrum Compact CE Benchtop DNA Analysis Instrument with...
MADISON, Wis. Promega today launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system...
View ArticleClik here to view.
LUCA Science Announces $9.8 Million Series A Financing to Support Research...
TOKYO LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of a $9.8 million Series...
View ArticleClik here to view.
Regent Pacific to Acquire Longevity AI Startup Deep Longevity for HK$29.56...
HONG KONG Deep Longevity, Inc (“DLI”), a leader in artificial intelligence for aging and longevity research, announced that it has entered into an agreement to be acquired for a potential...
View ArticleClik here to view.
Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in...
CHENNAI, India A 16 years old boy from Chennai who was suffering from decompensated chronic liver disease due to ‘Cholesteryl ester storage disease’, has undergone successful liver transplant at...
View ArticleClik here to view.
CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy...
BEIJING & CAMBRIDGE, Mass CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions, announced that it has...
View ArticleClik here to view.
D＆D Pharmatech Announces Launch of Valted Seq Subsidiary Focusing on...
GYEONGGI-DO, South Korea & GAITHERSBURG, Md. D&D Pharmatech, Inc. (D&D), a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines,...
View ArticleClik here to view.
S2 Genomics Announces Asia-Pacific Distribution Partnerships for the...
LIVERMORE, Calif. S2 Genomics, Inc., today announced that it has entered into distribution agreements with SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio for the promotion, sales, and...
View Article